FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
Relay Therapeutics' (Nasdaq: RLAY) stock is trading nearly 9% lower after-hours Monday after the company announced plans to offer $350 million of shares of its common stock in an underwritten public offering, with an intention to grant the underwriters a 30-day option for purchasing... More

